Employees
51–200
Founded
2019
Business Model
B2B
Last Round
Series CAug 2025
Rounds
2

About

Develops bio- and micro-interventional ophthalmic surgical technologies to treat glaucoma and improve aqueous outflow.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series CSeries CAug 2025

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies